CClinicalTrials.gg
RecruitingNCT06896279Updated Dec 16, 2025

Study on the Effectiveness and Safety of Temporal Interference Stimulation in Treating Patients With Severe Consciousness Disorders

An interventional study of TI Stimulation and Sham Stimulation in Disorder of Consciousness and Temporal Interference Stimulation, sponsored by Huashan Hospital. Recruiting at 2 sites in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-12-16.

Sponsored by Huashan Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Apr 2025; still recruiting 1 year 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Investigating the efficacy and safety of temporal interference stimulation for patients with disorders of consciousness.

Read the detailed description

Based on the central loop hypothesis, deep brain stimulation (DBS) represents a commonly utilized neuro-modulation stimulation technology for disorders of consciousness (DOC). It was initially employed in Europe in 1968 for treating DOC. Some patients can regain functional communication capabilities and even resume family life. Nevertheless, as a neurosurgical intervention, DBS implantation entails significant surgical risks and potential complications (such as cerebral edema in the surgical area, secondary cerebral hemorrhage, secondary epilepsy, postoperative brain abscess, pulse generator shutdown or circuit malfunction, displacement of stimulation electrodes or extension leads, rejection reactions), and incurs substantial costs, imposing a heavy burden on patients' families and the national medical insurance fund. Traditional non-invasive brain stimulation methods, such as transcranial alternating or direct current stimulation, although not requiring surgery, have limited focusing capacity and the ability to stimulate deep brain structures. Hence, researchers have been in pursuit of approaches to precisely and effectively stimulate deep brain regions without the need for surgery.

In 2017, the concept of temporal interference (TI) stimulation, a novel non-invasive method for regulating deep brain regions was put forward . The fundamental principle of TI stimulation is that two interfering high-frequency signals will generate a low-frequency amplitude-modulated electric field, which can drive the discharge of deep brain neurons. Furthermore, by fixing the sum of the input currents of two pairs of electrodes and altering the current input ratio of the two pairs of electrodes, the movement of the mouse's forepaws, whiskers, and ears without modifying the spatial position of the electrodes could be achieved. Therefore, TI stimulation enables the flexible movement of the stimulation target area within the brain without electrode displacement. Despite the fact that research on TI technology is still in its nascent stage, this method has demonstrated substantial potential in neuroscience and clinical therapy.

Consequently, the objective of this multicenter randomized controlled trial is to assess the therapeutic effect of temporal interference stimulation in awakening patients with severe disorders of consciousness and verify its safety. Simultaneously, it aims to clarify issues such as the clinical application indications, operational parameters of TI. This will facilitate a deeper comprehension of the effectiveness, clinical application indications, operational parameters, and treatment plans of this emerging neuro-modulation technology as a means of awakening treatment, and promote the advancement of diagnosis and treatment technologies for patients with severe disorders of consciousness.

02

Conditions studied

  • Disorder of Consciousness
  • Temporal Interference Stimulation

Keywords

  • Disorder of Consciousness
  • Randomized clinical trail
  • Temporal Interference Stimulation
03

In context

Consciousness Disorders

236 studies on the registry are indexed under Consciousness Disorders; 102 are open to participants now.

This study's planned enrollment of 20 is below the median of 40 across 147 interventional studies indexed under Consciousness Disorders.

Browse Consciousness Disorders studies →

Lead sponsor

Huashan Hospital is the lead sponsor of 239 studies on the registry; 102 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Severe consciousness disorder patients aged 18 to 75 years old, regardless of gender;
  • Patients with severe consciousness disorders, namely a minimally conscious state or vegetative state that lasts for 28 days or more;
  • Patients with normal body temperature, stable vital signs, spontaneous breathing, tracheotomy without the use of a metal cannula and with a small amount of sputum, and who are eligible for magnetic resonance imaging (MRI) examination;
  • Written informed consent obtained from the patient's family members in advance.

Exclusion criteria

Exclusion Criteria:

  • Individuals with a previous history of significant neuropsychiatric and other major disorders such as those involving the heart, lung, liver, and kidney;
  • Those who have undergone V-P shunt or Ommaya reservoir implantation and other procedures that may influence the analysis of magnetic resonance scanning signals;
  • Patients who are scheduled for V-P shunt or Ommaya reservoir implantation in the near future;
  • Pregnant women;
  • Those who have participated in other drug or device clinical trials;
  • Patients with poorly controlled epilepsy in the recent period;
  • Those with infections at the TI stimulation site or compromised skin integrity at the electrode placement site;
  • Those currently taking medications prone to inducing epilepsy, such as quinolone drugs;
  • Those with intracranial infections, intracranial tumors, or metallic objects within the cranium;
  • Those allergic to electrode gel or adhesives;
  • Those with implanted electronic devices within the body;
  • Those with severe cardiac disorders and those equipped with cardiac pacemakers.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    TI stimulation group

    The two high-frequency electric fields of the TI device are set at different frequencies, thereby resulting in the generation of a low-frequency electric field that is capable of triggering brain physiological responses. The duration is 10 minutes.

    Procedure: TI Stimulation

  • Sham comparator
    Sham TI stimulation group

    The two high-frequency electric fields of the TI device are set to be completely of the same frequency (2000Hz), thus no low-frequency electric field is produced and no cerebral physiological responses are elicited. The duration lasts for 10 minutes.

    Procedure: Sham Stimulation

Interventions

  • ProcedureTI Stimulation

    Participants will accept the TI stimulus for one month

  • ProcedureSham Stimulation

    Participants will accept the sham TI stimulus for one month

06

What researchers measure

Primary outcomes

  1. Effective rate of awakening

    The CRS-R is employed, with a minimum of 5 CRS-R assessments conducted at each follow-up time point, accompanied by simultaneous video recording. And the highest value is scored as a state of consciousness. The clinical assessment of participants' consciousness is deemed significantly improved when it fulfills the following criteria: a) MCS- recover to consciousness level of MCS+ or higher; b) Vegetative state(VS) recover to consciousness level of MCS- or higher; c) MCS status (MCS- or MCS+) recover to emergence from MCS (restoration of functional communication).

    Time frame: Stimulation for 1 month

Secondary outcomes

  1. The difference of CRS-R scale relative to baseline between TI group and sham group

    The Coma Recovery Scale-Revised (CRS-R) is a standardized neurobehavioral assessment measure designed for use in patients with disorders of consciousness. It has good validity, reliability and practicability.

    Time frame: Stimulation begin for 14 days, 1 month and 3 months

  2. The difference of Simplified Evaluation of CONsciousness Disorders (SECONDs) scale relative to baseline between TI group and sham group

    The SECONDs is a fast tool to assess consciousness in brain-injured patients. The minimum score is 0 and the maximum is 8, higher scores mean a better outcome.

    Time frame: Stimulation begin for 14 days, 1 month and 3 months

  3. The difference of modified Ashworth scale relative to baseline between TI group and sham group

    The modified Ashworth scale is the most universally accepted clinical tool used to measure the increase of muscle tone. The minimum grade is 0 and the maximum is 4, higher scores mean a worse outcome.

    Time frame: Stimulation begin for 14 days, 1 month and 3 months

  4. The difference of Nociception Coma Scale-Revised (NCS-R) scale relative to baseline between TI group and sham group

    The NCS-R was developed to help assess pain in patients with disorders of consciousness (DOC). Several studies have shown its sensitivity in assessing response to acute noxious stimuli. The minimum score is 0 and the maximum is 12, higher scores mean a better outcome.

    Time frame: Stimulation begin for 14 days, 1 month and 3 months

  5. The difference of effective rate of awakening between TI group and sham group by CRS-R scale

    The Coma Recovery Scale-Revised (CRS-R) is a standardized neurobehavioral assessment measure designed for use in patients with disorders of consciousness. It has good validity, reliability and practicability.

    Time frame: Stimulation begin for 1 month and 3 months

  6. The difference of effective rate of awakening between TI group and sham group by Simplified Evaluation of CONsciousness Disorders (SECONDs) scale

    The SECONDs is a fast tool to assess consciousness in brain-injured patients. The minimum score is 0 and the maximum is 8, higher scores mean a better outcome.

    Time frame: Stimulation begin for 1 month and 3 months

  7. The difference of recovery trajectories of consciousness level between TI group and Sham group

    Time frame: Stimulation for 3-month-stimulation

07

Study locations

2 of 2 sites recruiting
  • Department of neurological rehabilitation, Shanghai First Rehabilitation Hospital, Tongji University
    Shanghai, Shanghai Municipality 200000, China
    Recruiting
  • Department of Neurosurgery, Huashan Hospital, Fudan University
    Shanghai, Shanghai Municipality 200000, China
    Recruiting
08

References and documents

Publications

  • Violante IR, Alania K, Cassara AM, Neufeld E, Acerbo E, Carron R, Williamson A, Kurtin DL, Rhodes E, Hampshire A, Kuster N, Boyden ES, Pascual-Leone A, Grossman N. Non-invasive temporal interference electrical stimulation of the human hippocampus. Nat Neurosci. 2023 Nov;26(11):1994-2004. doi: 10.1038/s41593-023-01456-8. Epub 2023 Oct 19. PubMed 37857775 ↗
  • Thibaut A, Schiff N, Giacino J, Laureys S, Gosseries O. Therapeutic interventions in patients with prolonged disorders of consciousness. Lancet Neurol. 2019 Jun;18(6):600-614. doi: 10.1016/S1474-4422(19)30031-6. Epub 2019 Apr 16. PubMed 31003899 ↗
  • Giacino JT, Katz DI, Schiff ND, Whyte J, Ashman EJ, Ashwal S, Barbano R, Hammond FM, Laureys S, Ling GSF, Nakase-Richardson R, Seel RT, Yablon S, Getchius TSD, Gronseth GS, Armstrong MJ. Practice guideline update recommendations summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research. Neurology. 2018 Sep 4;91(10):450-460. doi: 10.1212/WNL.0000000000005926. Epub 2018 Aug 8. PubMed 30089618 ↗
  • Grossman N, Bono D, Dedic N, Kodandaramaiah SB, Rudenko A, Suk HJ, Cassara AM, Neufeld E, Kuster N, Tsai LH, Pascual-Leone A, Boyden ES. Noninvasive Deep Brain Stimulation via Temporally Interfering Electric Fields. Cell. 2017 Jun 1;169(6):1029-1041.e16. doi: 10.1016/j.cell.2017.05.024. PubMed 28575667 ↗
  • Tasserie J, Uhrig L, Sitt JD, Manasova D, Dupont M, Dehaene S, Jarraya B. Deep brain stimulation of the thalamus restores signatures of consciousness in a nonhuman primate model. Sci Adv. 2022 Mar 18;8(11):eabl5547. doi: 10.1126/sciadv.abl5547. Epub 2022 Mar 18. PubMed 35302854 ↗
  • Schiff ND. Recovery of consciousness after brain injury: a mesocircuit hypothesis. Trends Neurosci. 2010 Jan;33(1):1-9. doi: 10.1016/j.tins.2009.11.002. Epub 2009 Dec 1. PubMed 19954851 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06896279
Lead sponsor
Huashan Hospital
Collaborators
Shanghai First Rehabilitation Hospital
Responsible party
Xuehai Wu (Deputy Director of Shanghai Neurosurgical Emergency Center, Huashan Hospital) — Principal investigator
First posted
Mar 26, 2025
Start date
Apr 21, 2025
Primary completion
May 16, 2026 (estimated)
Completion
May 17, 2026 (estimated)
Last update
Dec 16, 2025

Study contacts

Xuehai Wu, Ph.D.
Contact
Wuxuehai2013@163.com
+86 13764880571
Wentao Huang, M.M.
Contact
hhuangwt7777@163.com
+86 19370557372
Xuehai Wu, Ph.D.
principal investigator · Department of Neurosurgery, Huashan Hospital, Fudan University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion